EUVIMEDEUVIMED entdecken
Crossref

Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV ‐1 in Türkiye

Adem Özdemir iD, Tülin Demir, Ceylan Polat iD, Mertcan Uzun, Meliha Çağla Sönmezer, Koray Ergünay, Serhat Ünal, Ahmet Çağkan İnkaya iD, Ahmet Pınar

HIV Medicine · 2025

DOI: 10.1111/hiv.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HIV Medicine, 2025. Verfasst von Adem Özdemir und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Mamak State Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Anti-HIV Agents. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Gilead Research Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Monitoring transmitted drug resistance is crucial for guiding first‐line antiretroviral therapy (ART) and controlling the rising HIV epidemic in Türkiye. This study aimed to determine the prevalence of transmitted antiretroviral resistance to protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), non‐nucleoside reverse transcriptase inhibitors (NNRTIs), integrase strand transfer inhibitors (INSTIs) and capsid assembly inhibitors (CAIs). We also assessed the distribution of HIV‐1 subtypes and circulating recombinant forms (CRFs) at one of the main national referral centres in Türkiye.

Methods

We included 104 consecutive ART‐naïve people living with HIV who presented at Hacettepe University Hospital in Ankara between November 2021 and November 2022. Demographic data, probable transmission routes and geographic origins were recorded. HIV‐1 genotyping was performed to identify subtypes and resistance‐associated mutations using standard methods.

Results

Of the 104 individuals, 97 were from 25 different cities in Türkiye, while 7 originated from 5 different countries. The most probable transmission routes were men who have sex with men (MSM) (64.42%), heterosexual contact (30.77%) and unknown (4.81%). Resistance‐associated mutations were detected in 14.42% of individuals. Resistance rates were 1.92% for PI, 4.80% for NRTI and 7.69% for NNRTI. No resistance mutations were found against INSTI or CAI.

Conclusion

Transmitted resistance to PI, NRTI and NNRTI remains present in Türkiye, though at moderate levels. The absence of resistance to INSTI and CAI supports their potential utility as effective components of treatment regimens in Türkiye.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsDrug Resistance, ViralAnti-HIV AgentsHumansMaleFemaleAdultMiddle AgedMolecular EpidemiologyTurkeyGenotypeYoung AdultPrevalenceMutation

Stichwörter der Autor:innen

HIV‐1antiretroviral therapydrug resistancesubtypesurveillance

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Medical Microbiology, Mamak State Hospital, Ankara, Türkiye.
  • Department of Medical Microbiology, Kirsehir Research and Training Hospital, Kirsehir, Türkiye.
  • Formerly National HIV-AIDS and Viral Hepatitis Reference Laboratory, Reference Laboratories and Biological Products, General Directorate of Public Health, Ministry of Health, Ankara, Türkiye.
  • Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
  • Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Türkiye.
  • Department of Entomology, Smithsonian Institution-National Museum of Natural History (NMNH), Washington, DC, USA.

ORCID-Profile: Adem Özdemir, Ceylan Polat, Ahmet Çağkan İnkaya

Förderung

  • Gilead Research Scholars

Zitieren

APA

Özdemir, A., Demir, T., Polat, C., Uzun, M., Sönmezer, M. Ç., Ergünay, K., Ünal, S., İnkaya, A. Ç., & Pınar, A. (2025). Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV ‐1 in Türkiye. HIV Medicine. https://doi.org/10.1111/hiv.70109

Vancouver

Özdemir A, Demir T, Polat C, Uzun M, Sönmezer MÇ, Ergünay K, et al. Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV ‐1 in Türkiye. HIV Medicine. 2025. doi:10.1111/hiv.70109

BibTeX
@article{zdemir2025,
  author = {Özdemir, Adem and Demir, Tülin and Polat, Ceylan and Uzun, Mertcan and Sönmezer, Meliha Çağla and Ergünay, Koray and Ünal, Serhat and İnkaya, Ahmet Çağkan and Pınar, Ahmet},
  title = {Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV ‐1 in Türkiye},
  journal = {HIV Medicine},
  year = {2025},
  doi = {10.1111/hiv.70109}
}
Kostenlos starten →